An unusual interaction between the target of nalidixic acid and novobiocin.

Nalidixic acid: an antibacterial paradox.

Synergism between fosfomycin and nalidixic acid in vitro.

Convulsions and hyperglycaemia associated with nalidixic acid.

LE-like disease caused by nalidixic acid.

Toxicity and carcinogenicity studies of nalidixic acid in rodents.

The mechanism of photohaemolysis by photoproducts of nalidixic acid.

R-plasmid transfer and its response to nalidixic acid.

The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.

Novobiocin, an antagonist of leukotriene B4.

Gas chromatographic determination of nalidixic acid in tablets.

An unusual protein-protein interaction through coupled unfolding and binding.

Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid.

Drug Resistance Reversal Potential of Ursolic Acid Derivatives against Nalidixic Acid- and Multidrug-resistant Escherichia coli.

Benign intracranial hypertension after nalidixic acid overdose in infants.

[Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].

Population changes induced in Candida albicans by nalidixic acid.

Nalidixic acid-induced protein alterations in Escherichia coli.

Cockarde (target-like lesion) seborrheic keratosis: an unusual clinical pattern.

DNA injection and genetic recombination of alkylated bacteriophage T7 in the presence of nalidixic acid.

Decarboxylation and singlet oxygen production in the photolysis of nalidixic acid.

Possible interaction between an MAOI and "ecstasy".

The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.

Antagonistic interaction between jasmonic acid and cytokinin in xylem development.

Pharmacokinetic Interaction Between Valproic Acid, Meropenem, and Risperidone.

Suggest Documents

Nalidixic acid: an antibacterial paradox.

Synergism between fosfomycin and nalidixic acid in vitro.

Convulsions and hyperglycaemia associated with nalidixic acid.

LE-like disease caused by nalidixic acid.

Toxicity and carcinogenicity studies of nalidixic acid in rodents.

The mechanism of photohaemolysis by photoproducts of nalidixic acid.

R-plasmid transfer and its response to nalidixic acid.

The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.

Novobiocin, an antagonist of leukotriene B4.

Gas chromatographic determination of nalidixic acid in tablets.

An unusual protein-protein interaction through coupled unfolding and binding.

Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid.

Drug Resistance Reversal Potential of Ursolic Acid Derivatives against Nalidixic Acid- and Multidrug-resistant Escherichia coli.

Benign intracranial hypertension after nalidixic acid overdose in infants.

[Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].

Population changes induced in Candida albicans by nalidixic acid.

Nalidixic acid-induced protein alterations in Escherichia coli.

Cockarde (target-like lesion) seborrheic keratosis: an unusual clinical pattern.

DNA injection and genetic recombination of alkylated bacteriophage T7 in the presence of nalidixic acid.

Decarboxylation and singlet oxygen production in the photolysis of nalidixic acid.

Possible interaction between an MAOI and "ecstasy".

The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.

Antagonistic interaction between jasmonic acid and cytokinin in xylem development.

Pharmacokinetic Interaction Between Valproic Acid, Meropenem, and Risperidone.

An unusual interaction between the target of nalidixic acid and novobiocin.

Recommend Documents

Follow Us